Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
Lantheus
LNTH
US OptionsDetailed Quotes
INCY250516C40000
- 0.00
- 0.000.00%
15min DelayClose Apr 30 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest40.00Strike Price0.00Turnover0.00%IV-36.16%PremiumMay 16, 2025Expiry Date22.66Intrinsic Value100Multiplier15DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.76Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Incyte Newsroom
Incyte's Promising Drug Pipeline and Strong Financial Performance Reinforce Buy Rating
TD Cowen Lowers Price Target on Incyte to $86 From $88
Incyte Price Target Raised to $59.00/Share From $58.00 by Wells Fargo
Wells Fargo Maintains Equal-Weight on Incyte, Raises Price Target to $59
Incyte Is Maintained at Sector Perform by RBC Capital
Incyte Analyst Ratings
Morgan Stanley Adjusts Incyte's Price Target to $68 From $65
RBC Raises Price Target on Incyte to $67 From $64, Keeps Sector Perform Rating
Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH), Incyte (INCY) and Verona Pharma (VRNA)
TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Cuts Target Price to $86
BofA Securities Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $89
Wells Fargo Hikes Price Target on Incyte to $59 From $58
Jefferies Adjusts Incyte Price Target to $76 From $75
Research Alert: Incy Posts Robust Q1 Results, Beating Expectations
William Blair Maintains Incyte(INCY.US) With Hold Rating
Incyte's Mixed Performance and Future Uncertainties Justify Hold Rating
J.P. Morgan Maintains Incyte(INCY.US) With Hold Rating, Announces Target Price $68
Incyte Is Maintained at Neutral by JP Morgan
Incyte Analyst Ratings
JPMorgan Adjusts Incyte Price Target to $68 From $70, Maintains Neutral Rating
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
